HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.

AuthorsK Ohashi, A Sato, T Takada, T Arai, Y Kasahara, M Hojo, T Nei, H Nakayama, N Motoi, S Urano, R Eda, M Yokoba, Y Tsuchihashi, Y Nasuhara, H Ishii, M Ebina, E Yamaguchi, Y Inoue, K Nakata, R Tazawa
JournalThe European respiratory journal (Eur Respir J) Vol. 39 Issue 3 Pg. 777-80 (Mar 2012) ISSN: 1399-3003 [Electronic] England
PMID22379153 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Oxygen
Topics
  • Autoantibodies (blood, immunology)
  • Autoimmune Diseases (blood, immunology)
  • Bronchoalveolar Lavage Fluid (chemistry, immunology)
  • Clinical Trials, Phase II as Topic
  • Granulocyte-Macrophage Colony-Stimulating Factor (immunology, therapeutic use)
  • Humans
  • Lung (drug effects, physiopathology)
  • Macrophages, Alveolar (drug effects, immunology)
  • Multicenter Studies as Topic
  • Oxygen (blood)
  • Pulmonary Alveolar Proteinosis (blood, immunology, physiopathology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: